Free Trial

HC Wainwright's Rating of 12244 (ASM.V) on 8/19/2019

On August 19, 2019, HC Wainwright updated its outlook on 12244 (ASM.V) (CVE:ASM) with the action "Boost Price Target", setting a price target of C$1.75. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
9/17/2025
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
Boost Price Target
9/17/2025
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
Reiterated Rating
9/17/2025
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
Boost Price Target
9/17/2025
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
Boost Price Target
9/17/2025
SoundHound AI, Inc. stock logo
SOUN
SoundHound AI
Reiterated Rating
9/17/2025
Americas Gold and Silver Corporation stock logo
USAS
Americas Gold and Silver
Boost Price Target
More Ratings From HC Wainwright